- Home
- ZKH vs VSTM Comparison
ZKH vs VSTM Comparison
Compare ZKH & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKH
- VSTM
- Stock Information
- Founded
- ZKH 1998
- VSTM 2010
- Country
- ZKH China
- VSTM United States
- Employees
- ZKH N/A
- VSTM N/A
- Industry
- ZKH
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- ZKH
- VSTM Health Care
- Exchange
- ZKH Nasdaq
- VSTM Nasdaq
- Market Cap
- ZKH 472.2M
- VSTM 425.9M
- IPO Year
- ZKH 2023
- VSTM 2012
- Fundamental
- Price
- ZKH $2.78
- VSTM $7.08
- Analyst Decision
- ZKH Buy
- VSTM Strong Buy
- Analyst Count
- ZKH 1
- VSTM 9
- Target Price
- ZKH $4.00
- VSTM $13.63
- AVG Volume (30 Days)
- ZKH 22.6K
- VSTM 2.1M
- Earning Date
- ZKH 05-20-2025
- VSTM 05-13-2025
- Dividend Yield
- ZKH N/A
- VSTM N/A
- EPS Growth
- ZKH N/A
- VSTM N/A
- EPS
- ZKH N/A
- VSTM N/A
- Revenue
- ZKH $1,217,705,644.00
- VSTM $10,000,000.00
- Revenue This Year
- ZKH $11.95
- VSTM $106.87
- Revenue Next Year
- ZKH $11.23
- VSTM $312.95
- P/E Ratio
- ZKH N/A
- VSTM N/A
- Revenue Growth
- ZKH 2.24
- VSTM N/A
- 52 Week Low
- ZKH $2.50
- VSTM $2.10
- 52 Week High
- ZKH $13.97
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- ZKH 42.77
- VSTM 47.31
- Support Level
- ZKH $2.60
- VSTM $7.60
- Resistance Level
- ZKH $3.16
- VSTM $9.10
- Average True Range (ATR)
- ZKH 0.24
- VSTM 0.88
- MACD
- ZKH -0.00
- VSTM -0.09
- Stochastic Oscillator
- ZKH 42.55
- VSTM 33.16
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.